Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope and concerns about transparency and ethics.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

The company brings together AI experts and experienced pharmaceutical scientists to build what Murdoch calls a “world-class drug design engine.” In 2024, Isomorphic signed major research deals ...

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often ...